|Articles|March 23, 2022
Minimize Risks and Enhance Speed and Flexibility with Sterile Fill/Finish Support for Clinical Supplies
Author(s)Eurofins BioPharma Product Testing
Join Eurofins BioPharma Product Testing and Vanrx (now part of Cytiva), for an in-depth discussion covering ways to eliminate human error and other associated risks when producing small batches of sterile GMP product for Phase 1 and 2 clinical trials.
Related Content
Trending on Pharmaceutical Technology
1
CPHI Milan Names 2026 Pharma Awards Finalists
2
Lilly's $2.875B Merida Deal Has Implications for Autoantibody Diseases
3
From Phase 1 Screening to Commercial Strategy: Selecting the Right Amorphous Solid Dispersion Technology Early
4
AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 1
5